Evolus, Inc. (EOLS) stock forecast and price target
Price $6.96 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($6.96)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.03 | +92.6% | $334M |
| Next fiscal year ends December 31, 2027 | $0.29 | +984.6% | $391M |
| Next quarter ends December 31, 2026 | $0.04 | +184.1% | $99M |
| Quarter after ends March 31, 2027 | $0.00 | +100.0% | $88M |
Consensus of the analysts covering Evolus, updated daily.
Our model vs. Wall Street
Analysts see 121.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Evolus’s intrinsic value about 64% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Evolus stock price target?
The average 12-month target from 5 analysts is $15.40, 121.3% above the current price of $6.96 Targets range from $12.00 to $20.00.
Is Evolus a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 4 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Evolus expected to earn?
Analysts expect EPS of $-0.03 for the fiscal year ending December 31, 2026 and $0.29 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.